A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity.

Mutant contractile protein genes that cause familial hypertrophic cardiomyopathy (FHC) are presumed to encode mutant proteins that interfere with contractile function. However, it has generally not been possible to show mutant protein expression and incorporation into the sarcomere in vivo. This study aimed to assess whether a mutant alpha-fast tropomyosin (TM) responsible for FHC is actually expressed and determines abnormal contractile function. Since alpha-fast TM is expressed in heart and skeletal muscle, samples from vastus lateralis muscles were studied from two FHC patients carrying an Asp175Asn alpha-fast TM mutation and two healthy control subjects. TM isoforms from whole biopsy samples and single fibers were identified by gel electrophoresis and Western blot analysis. An additional faster-migrating TM band was observed in both FHC patients. The aberrant TM was identified as the Asp175Asn alpha-fast TM by comigration with purified recombinant human Asp175Asn alpha-fast TM. Densitometric quantification of mutant and wild-type alpha-fast TMs suggested equal expression of the two proteins. Contractile parameters of single skinned muscle fibers from FHC patients and healthy control subjects were compared. Calcium sensitivity was significantly increased in muscle fibers containing Asp175Asn alpha-fast Tm compared with fibers lacking the mutant TM. No discernible difference was found regarding cooperativity, maximum force, and maximum shortening velocity. This is the first demonstration that the mutant TM that causes FHC is indeed expressed and almost certainly incorporated into muscle in vivo and does result in altered contractile function; this confirms a dominant-negative, rather than null allele, action. Since the mutant TM was associated with increased calcium sensitivity, this mutation might be associated with an enhancement and not a depression of cardiac contractile performance. If so, this contrasts with the hypothesis that FHC mutations induce contractile impairment followed by compensatory hypertrophy.

[1]  H. Watkins,et al.  Effects of two hypertrophic cardiomyopathy mutations in alpha-tropomyosin, Asp175Asn and Glu180Gly, on Ca2+ regulation of thin filament motility. , 1997, Biochemical and biophysical research communications.

[2]  J. Seidman,et al.  Effects of two familial hypertrophic cardiomyopathy-causing mutations on alpha-tropomyosin structure and function. , 1997, Biochemistry.

[3]  J. Seidman,et al.  Clinical features of hypertrophic cardiomyopathy caused by mutation of a "hot spot" in the alpha-tropomyosin gene. , 1997, Journal of the American College of Cardiology.

[4]  J. Seidman,et al.  Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. Evidence for a dominant negative action. , 1996, The Journal of clinical investigation.

[5]  C. Reggiani,et al.  Force‐velocity properties of human skeletal muscle fibres: myosin heavy chain isoform and temperature dependence. , 1996, The Journal of physiology.

[6]  E. Homsher,et al.  Altered cardiac troponin T in vitro function in the presence of a mutation implicated in familial hypertrophic cardiomyopathy. , 1996, The Journal of clinical investigation.

[7]  C. Reggiani,et al.  Myofibrillar ATPase activity in skinned human skeletal muscle fibres: fibre type and temperature dependence. , 1996, The Journal of physiology.

[8]  Frederick J. Schoen,et al.  A Mouse Model of Familial Hypertrophic Cardiomyopathy , 1996, Science.

[9]  I. Rayment,et al.  Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle , 1996, Nature Genetics.

[10]  C. Reggiani,et al.  Molecular diversity of myofibrillar proteins: gene regulation and functional significance. , 1996, Physiological reviews.

[11]  L. Leinwand,et al.  Contractile protein mutations and heart disease. , 1996, Current opinion in cell biology.

[12]  J. Seidman,et al.  Mutations in the cardiac myosin binding protein–C gene on chromosome 11 cause familial hypertrophic cardiomyopathy , 1995, Nature Genetics.

[13]  J. Beckmann,et al.  Cardiac myosin binding protein–C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy , 1995, Nature Genetics.

[14]  J. Seidman,et al.  Familial hypertrophic cardiomyopathy: a genetic model of cardiac hypertrophy. , 1995, Human molecular genetics.

[15]  T. Kishimoto,et al.  Novel missense mutation in α-tropomyosin gene found in Japanese patients with hypertrophic cardiomyopathy , 1995 .

[16]  J. Seidman,et al.  A De Novo Mutation in α-Tropomyosin That Causes Hypertrophic Cardiomyopathy , 1995 .

[17]  L. Fananapazir,et al.  Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. , 1995, The Journal of clinical investigation.

[18]  T. Yanagida,et al.  Direct measurement of stiffness of single actin filaments with and without tropomyosin by in vitro nanomanipulation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C. Reggiani,et al.  Unloaded shortening velocity and myosin heavy chain and alkali light chain isoform composition in rat skeletal muscle fibres. , 1994, The Journal of physiology.

[20]  F. Reinach,et al.  Functional alpha-tropomyosin produced in Escherichia coli. A dipeptide extension can substitute the amino-terminal acetyl group. , 1994, The Journal of biological chemistry.

[21]  W. Zhu,et al.  Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy. , 1993, The Journal of clinical investigation.

[22]  R. Roberts,et al.  Hypertrophic Cardiomyopathy Mutation Is Expressed in Messenger RNA of Skeletal as Well as Cardiac Muscle , 1993, Circulation.

[23]  A. Marian,et al.  Expression of a missense mutation in the messenger RNA for beta-myosin heavy chain in myocardial tissue in hypertrophic cardiomyopathy. , 1992, The Journal of clinical investigation.

[24]  M. Downes,et al.  Nonradioactive nucleic acid detection by enhanced chemiluminescence using probes directly labeled with horseradish peroxidase. , 1990, Analytical biochemistry.

[25]  M. Way,et al.  Expression of human plasma gelsolin in Escherichia coli and dissection of actin binding sites by segmental deletion mutagenesis , 1989, The Journal of cell biology.

[26]  C. Gooding,et al.  Human hTM alpha gene: expression in muscle and nonmuscle tissue , 1988, Molecular and cellular biology.

[27]  M. Diamond,et al.  Effect of different troponin T-tropomyosin combinations on thin filament activation. , 1987, Journal of molecular biology.

[28]  P W Brandt,et al.  Co-operative interactions between troponin-tropomyosin units extend the length of the thin filament in skeletal muscle. , 1987, Journal of molecular biology.

[29]  D. Danieli Betto,et al.  Type 1, 2A, and 2B myosin heavy chain electrophoretic analysis of rat muscle fibers. , 1986, Biochemical and biophysical research communications.

[30]  M. Zeviani,et al.  Myofibrillar-protein isoforms and sarcoplasmic-reticulum Ca2+-transport activity of single human muscle fibres. , 1984, The Biochemical journal.

[31]  H. Towbin,et al.  Immunoblotting and dot immunobinding--current status and outlook. , 1984, Journal of immunological methods.

[32]  R. Moss,et al.  Improved methodology for analysis and quantitation of proteins on one-dimensional silver-stained slab gels. , 1983, Analytical biochemistry.

[33]  D. Danieli Betto,et al.  Polymorphism of myofibrillar proteins of rabbit skeletal-muscle fibres. An electrophoretic study of single fibres. , 1982, The Biochemical journal.

[34]  C. Heizmann,et al.  α‐ and β‐tropomyosin in typed single fibers of human skeletal muscle , 1981 .

[35]  L. Smillie,et al.  The amino acid sequence of rabbit cardiac tropomyosin. , 1980, The Journal of biological chemistry.

[36]  K. Edman.  The velocity of unloaded shortening and its relation to sarcomere length and isometric force in vertebrate muscle fibres. , 1979, The Journal of physiology.

[37]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[38]  Lehrer,et al.  Effects of two familial hypertrophic cardiomyopathy-causing mutations on alpha-tropomyosin structure and function , 1999, Biochemistry.

[39]  T. Kishimoto,et al.  Novel missense mutation in alpha-tropomyosin gene found in Japanese patients with hypertrophic cardiomyopathy. , 1995, Journal of molecular and cellular cardiology.

[40]  J. Seidman,et al.  A de novo mutation in alpha-tropomyosin that causes hypertrophic cardiomyopathy. , 1995, Circulation.

[41]  F. Studier,et al.  Use of T7 RNA polymerase to direct expression of cloned genes. , 1990, Methods in enzymology.

[42]  A. Fabiato,et al.  Computer programs for calculating total from specified free or free from specified total ionic concentrations in aqueous solutions containing multiple metals and ligands. , 1988, Methods in enzymology.

[43]  J. Potter,et al.  Structural aspects of troponin-tropomyosin regulation of skeletal muscle contraction. , 1987, Annual review of biophysics and biophysical chemistry.